Passkey Therapeutics
Latest round
- Seed
Last raised
- Jun 2024
Total raised
- $19M
Investors
- 6
About Passkey Therapeutics
Passkey Therapeutics, Inc.Founded by Bruce Beutel, Soumya Ray, and William Chen, Passkey Therapeutics, Inc. is headquartered in Cambridge, US, and specializes in creating advanced therapeutic solutions for multifaceted diseases.Passkey Therapeutics specializes in developing a new class of drugs known as Synergistic Multifunctional Therapeutics (SMThs) aimed at treating complex diseases such as cancer, autoimmune disorders, neurodegenerative diseases, and metabolic disorders. Their innovative approach leverages biological complexity by targeting Multilogs—unique combinations of proteins that interact synergistically—rather than focusing on single-protein targets. This method is facilitated through their proprietary integrated computational and experimental platform called Locksmith, which identifies these Multilogs and expands the landscape of potential drug targets. The company engages in B2B transactions, collaborating with pharmaceutical firms and healthcare organizations to develop and distribute its SMThs. Revenue generation involves milestone payments associated with drug development phases, collaborative research, and licensing agreements with established pharmaceutical companies.35 mn to develop a novel class of multifunctional medicines using a unique platform that targets uncommon protein combinations. The company aims to launch new products tailored for complex diseases and expand into global markets, including specific regions in North America and Europe, by 2025. With a focus on enhancing its research capabilities and accelerating drug development, Passkey is positioned to leverage its innovative platforms and collaborations to meet the increasing demand for advanced therapeutic options.
Who invested in Passkey Therapeutics
6 investors across 1 round
See all investors in Passkey Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 27, 2024
Amount
$19M
Investors
Questions about Passkey Therapeutics
Who invested in Passkey Therapeutics?
Passkey Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Passkey Therapeutics raised?
Passkey Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Passkey Therapeutics last raise money?
Passkey Therapeutics's most recent round on record is a Seed, in Jun 2024.
What does Passkey Therapeutics do?
Passkey Therapeutics is a biotechnology company.
Where is Passkey Therapeutics headquartered?
Passkey Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Passkey Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Passkey Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Passkey Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.